Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer
CONCLUSION: Moderate hypofractionated PBT may be a useful radiotherapy method for centrally located cT1-T4N0M0 NSCLC.PMID:37097674 | DOI:10.21873/anticanres.16361
Source: Cell Research - Category: Cytology Authors: Masatoshi Nakamura Hitoshi Ishikawa Kayoko Ohnishi Keiichiro Baba Taisuke Sumiya Motohiro Murakami Yuichi Hiroshima Masashi Mizumoto Toshiyuki Okumura Hideyuki Sakurai Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Lung Cancer | Non-Small Cell Lung Cancer | Proton Therapy